Lijun Yan
No. 10, Tieyi Road, Yangfangdian Street
Haidian, 100038, China
Haidian, 100038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Multiple surgical interventions improve survival in locally recurrent retroperitoneal sarcoma: a retrospective cohort analysis.
Journal: Frontiers in oncology
Published: February 12, 2025
Fibronectin 1 Aggravates Colon Cancer Metastasis by Regulating RAP1B Protein Stability Through Akt/CREB Signalling Pathway.
Journal: Journal of cellular and molecular medicine
Published: August 19, 2024
Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis.
Journal: World journal of surgical oncology
Published: May 29, 2024
Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients.
Journal: World journal of surgical oncology
Published: March 25, 2024
Identification of Potential Diagnostic and Prognostic Pseudogenes in Hepatocellular Carcinoma Based on Pseudogene-miRNA-mRNA Competitive Network.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: May 28, 2020
Prognostic Value and Molecular Regulatory Mechanism of MSTO2P in Hepatocellular Carcinoma: A Comprehensive Study Based on Bioinformatics, Clinical Analysis and in vitro Validation.
Journal: OncoTargets and therapy
Published: January 12, 2020
DUXAP8 a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation.
Journal: OncoTargets and therapy
Published: September 19, 2019
SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: August 23, 2019
Pseudogene DUXAP10 acts as a diagnostic and prognostic marker and promotes cell proliferation by activating PI3K/AKT pathway in hepatocellular carcinoma.
Journal: OncoTargets and therapy
Published: March 30, 2019
Pseudogene DUXAP10 can be used as a diagnostic and prognostic biomarker in human cancers.
Journal: Journal of cellular physiology
Published: March 13, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026